Zura Bio Limited (ZURA) Stock Analysis

What Zura Bio Limited does

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

Key metrics

ETFs linked to ZURA

Broad-market and Healthcare sector ETFs an investor holding Zura Bio Limited is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ZURA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Zura Bio Limited?

Zura Bio Limited trades under the ticker ZURA on NASDAQ.

Which exchange is ZURA listed on?

ZURA is listed on NASDAQ.

What sector does Zura Bio Limited operate in?

Zura Bio Limited is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ZURA in a portfolio?

PortView shows ZURA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.